» Articles » PMID: 23162295

Molecular Epidemiology of β-thalassemia in Pakistan: Far Reaching Implications

Overview
Specialty Genetics
Date 2012 Nov 20
PMID 23162295
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: β -Thalassaemia, an autosomal recessive hemoglobinopathy, is one of the commonest genetically transmitted disorders throughout the world. Collective measures including carrier identification, genetic counseling and prenatal diagnosis are required for preventing β-thalassemia.

Aim: To achieve this objective, Identification of the spectrum of genetic mutations, especially for various ethnic backgrounds in Pakistan. Therefore, we designed a cross sectional prospective study to identify the frequency of various gene mutations in different ethnic groups of Pakistan.

Materials And Methods: Over a 5-year period, DNA from 648 blood samples {including specimens of chorionic villus sampling (CVS)} were analyzed for the twelve most common β-thalassemia mutations found in the Pakistani population by a Multiplex amplification refractory mutation system (ARMS). Each sample was analyzed for the mutation as well as the normal gene, appropriate with negative and positive controls, and reagent blanks.

Results: Out of 648 samples mutations were identified in 640 (98.75%) samples by multiplex ARMS. 8 common β-thalassemia mutations were identified in 8 different ethnic groups accounting for 93.9% of the β-thalasemia alleles.

Conclusions: Based on the outcome of this study a cost effective proposal is formulated for detection of β-thalassemia mutations.

Citing Articles

A decade of molecular preimplantation genetic diagnosis of 350 blastomeres for beta-thalassemia combined with HLA typing, aneuploidy screening and sex selection in Iran.

Keshvar Y, Sabeghi S, Sharifi Z, Fatemi K, Fouladi P, Younesi Khah S BMC Pregnancy Childbirth. 2022; 22(1):330.

PMID: 35428248 PMC: 9013130. DOI: 10.1186/s12884-022-04660-9.


Health seeking behavior of β-thalassemia major children and its attributes: An epidemiological study in Eastern India.

Biswas B, Naskar N, Basu K, Dasgupta A, Basu R, Paul B J Family Med Prim Care. 2020; 9(7):3586-3592.

PMID: 33102334 PMC: 7567284. DOI: 10.4103/jfmpc.jfmpc_243_20.


Novel genetic therapeutic approaches for modulating the severity of β-thalassemia (Review).

Amjad F, Fatima T, Fayyaz T, Khan M, Qadeer M Biomed Rep. 2020; 13(5):48.

PMID: 32953110 PMC: 7484974. DOI: 10.3892/br.2020.1355.


Prevalence of Transfusion Transmissible Infections in Beta-Thalassemia Major Patients in Pakistan: A Systematic Review.

Ehsan H, Wahab A, Anwer F, Iftikhar R, Yousaf M Cureus. 2020; 12(8):e10070.

PMID: 32874814 PMC: 7455379. DOI: 10.7759/cureus.10070.


Enabling routine β-thalassemia Prevention and Patient Management by scalable, combined Thalassemia and Hemochromatosis Mutation Analysis.

Hashmi G, Qidwai A, Fernandez K, Seul M BMC Med Genet. 2020; 21(1):108.

PMID: 32414341 PMC: 7229588. DOI: 10.1186/s12881-020-01017-x.


References
1.
Khan S, Riazuddin S . Molecular characterization of beta-thalassemia in Pakistan. Hemoglobin. 1998; 22(4):333-45. DOI: 10.3109/03630269809071528. View

2.
Hafeez M, Aslam M, Ali A, Rashid Y, Jafri H . Regional and ethnic distribution of beta thalassemia mutations and effect of consanguinity in patients referred for prenatal diagnosis. J Coll Physicians Surg Pak. 2007; 17(3):144-7. DOI: 03.2007/JCPSP.144147. View

3.
Shpilberg O, Dorman J, Ferrell R, Trucco M, Shahar A, Kuller L . The next stage: molecular epidemiology. J Clin Epidemiol. 1997; 50(6):633-8. DOI: 10.1016/s0895-4356(97)00052-8. View

4.
Old J, Varawalla N, Weatherall D . Rapid detection and prenatal diagnosis of beta-thalassaemia: studies in Indian and Cypriot populations in the UK. Lancet. 1990; 336(8719):834-7. DOI: 10.1016/0140-6736(90)92338-i. View

5.
Ahmed S, Petrou M, Saleem M . Molecular genetics of beta-thalassaemia in Pakistan: a basis for prenatal diagnosis. Br J Haematol. 1996; 94(3):476-82. View